<DOC>
	<DOCNO>NCT01750606</DOCNO>
	<brief_summary>Retrospective study comply FDA 's post-market surveillance order . The purpose study contact patient receive Biomet metal-on-metal product primary total hip arthroplasty device . Patients revise prior contact ask submit blood draw , clinical exam MRI .</brief_summary>
	<brief_title>An MRI Investigation Soft Tissues Total Hip Arthroplasty</brief_title>
	<detailed_description>This study design estimate prevalence soft tissue change follow primary THA surgery patient receive one five Biomet implant type ; MOP primary THA , M2a 38 , M2a Taper , M2a Ringloc M2a Magnum MOM primary THA device 308-436 total patient four center . The primary objective study estimate prevalence soft tissue change unbiased MoM MoP sample . Secondary objective evaluate whether occurrence soft tissue change relate several potential covariates include patient implant characteristic time situ .</detailed_description>
	<criteria>patient meet sample plan requirement patient contraindicate MRI patient fail consent study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>